(Circulation. 2001;103:2839.)
© 2001 American Heart Association, Inc.
Basic Science Reports |
From the Department of Medicine, Emory University School of Medicine, and Veterans Administration Hospital, Atlanta, Ga (Y.C.C., J.B., D.G.H.), and the Institut für Pharmakologie und Klinische Pharmakologie, Heinrich-Heine-Universität, Duesseldorf, Germany (G.K.).
Correspondence to Georg Kojda, PharmD, PhD, Institut für Pharmakologie und Klinische Pharmakologie, Heinrich-Heine-Universität, Moorenstraße 5, 40225 Duesseldorf, Germany. E-mail kojda{at}uni-duesseldorf.de
| Abstract |
|---|
|
|
|---|
Methods and ResultsMale mice heterozygous for a disruption of the eNOS gene (eNOS+/-) and normal C56Bl/6J mice (eNOS+/+), 3 to 4 months of age, underwent exercise training for 3 weeks. Nontrained mice were exposed to the exercise environment (noise and vibration of the treadmill) without exercise for an identical period. In eNOS+/+ mice (n=7), exercise increased aortic eNOS protein expression by 3.4±0.4-fold (P<0.002). This was associated with a greater vascular cGMP accumulation on stimulation with acetylcholine (P<0.05). Furthermore, exercise training increased eNOS mRNA (1.78±0.4-fold) and protein (1.76±0.17-fold) in left ventricular tissue, as determined by competitive reverse transcriptionpolymerase chain reaction and Western analysis (P<0.05 for both). In striking contrast, exercise had no effect on aortic eNOS expression and cGMP accumulation in eNOS+/- mice (P>0.05). Thus, although eNOS expression appears to be normal in eNOS+/- mice under basal conditions, these mice are unable to increase eNOS expression during exercise.
ConclusionsThese findings show that regulation of eNOS expression during exercise requires the presence of both alleles of the gene and may have implications for conditions in which polymorphisms of eNOS are present in only 1 allele in humans. These individuals may have a normal vascular reactivity under basal conditions but may be unable to adapt their vascular reactivity in response to exercise training.
Key Words: exercise endothelium nitric oxide synthase genes cardiovascular disease
| Introduction |
|---|
|
|
|---|
In addition to the potentially beneficial effects of eNOS upregulation on exercise capacity, increased NO production may also reduce vascular disease.4 5 It is known that NO not only produces vasodilation but also inhibits platelet aggregation and has antioxidant, antiproliferative, and antiapoptotic properties.11 Pharmacological inhibition of NOS or disruption of the eNOS gene has been shown to accelerate the atherosclerotic process.12 13 14 Likewise, treatment with exogenous NO has been shown to reduce lesion formation in cholesterol-fed rabbits.15
Recently, there has been substantial interest in the role of polymorphisms of eNOS as they might contribute to cardiovascular disease. Indeed, 1 such polymorphism has been associated with an increased incidence of atherosclerosis and another with coronary vasospasm.16 17 In both of these cases, homozygotes with the polymorphism were affected, whereas heterozygotes were not. These results are of interest in light of recent observations we have made regarding the phenotype of mice heterozygous for the eNOS gene.18 These eNOS+/- mice were found to have normal blood pressure, heart rate, and soluble guanylate cyclase activity. Furthermore, vascular responses to a variety of endothelium-dependent and -independent vasoactive agents were identical to those observed in normal mice.
The above findings suggest that 1 eNOS gene provides sufficient eNOS protein expression and activity under basal conditions and raise questions about the significance of a heterozygous polymorphism of eNOS. A caveat in this regard is that various genetic alterations do not manifest themselves under normal circumstances but become apparent under conditions of stress. For example, individuals with sickle-cell trait do not suffer from sickle-cell crises unless exposed to high altitudes or severe hypoxia. Thus, it is conceivable that a loss of 1 eNOS gene might not be apparent under basal conditions but might become evident when eNOS gene expression should normally increase, for example, during exercise training. Thus, the purpose of this study was to determine whether eNOS+/- mice can increase vascular eNOS expression in response to exercise training.
| Methods |
|---|
|
|
|---|
Animals Studied
Mice heterozygous for the eNOS gene
(eNOS+/-) were
obtained by mating eNOS wild-type mice
(eNOS+/+, C57BL/6J) and mice lacking both
eNOS alleles (eNOS-/-) mice. All
mice studied were males. The eNOS-/-
mice were obtained from Jackson Laboratories and
had been backcrossed 10 times to the C57BL/6J
strain.19 Genotypes
of the offspring were identified from tail clippings by polymerase
chain reactions (PCR) as described
previously.18 Briefly, the
following primers were used to identify wild-type mice: sense,
5'-GCATCACCAGGAAGAAGACC-3' and antisense,
5'-GAGCCATACAGATGGTTGCC-3', and primers complementary to the
neomycin-resistance cassette were used to identify the presence of the
disrupting genetic insert (sense, 5'-CTCGACGTTGTCACTGAAGC-3' and
antisense, 5'-TCAAGAAGGCGATAGAAGGC-3'). In addition to these animals,
C57BL/6J mice were included as controls. Studies were performed when
the mice were 12 to 16 weeks of age. Mice were euthanized by
CO2 inhalation.
Determination of eNOS Protein Levels
Aortas were immersed in iced Tris buffer (5
mmol/L, pH 7.4) containing the protease inhibitors
leupeptin, benzamidine, aprotinin, PMSF, and antipain (10 µg/mL). The
tissues were homogenized for 30 seconds in a Polytron
homogenizer. The homogenates were then
centrifuged for 10 minutes at
100g to remove particulate
matter and unbroken cells. Total protein levels were determined by the
Bradford method.20 Western
blot analysis was performed as described
previously21 with a
commercially available monoclonal antibody (Transduction Laboratories)
and the ECL detection system (Amersham).
Determination of Vascular cGMP
Accumulation
Mouse aortas were freshly prepared, cut in half, and
equilibrated for 20 minutes at 37°C in polyethylene vials containing
Krebs-HEPES buffer (pH 7.4) supplemented with the phosphodiesterase
inhibitor zaprinast (500 µmol/L). The aortic rings were
incubated for 3 minutes with either acetylcholine or vehicle.
Incubation was stopped by immediate freezing in liquid nitrogen.
Thereafter, frozen artery rings were homogenized with a
Polytron in 500 µL ice-cold HClO4 (10%) and
then centrifuged at
4500g for 10 minutes. The
pellet was used for protein determination; 450 µL supernatant was
neutralized (pH 7.4) with
K3PO4,
centrifuged again, and directly used for determination of cGMP
by radioimmunoassay with 125I-labeled cGMP
as radiolabeled antigen. Preliminary experiments with this method
yielded recovery rates for cGMP and protein of
>90%.22
Determination of eNOS mRNA Expression
Expression of eNOS mRNA was measured with a
competitive reverse transcriptionPCR (cRT-PCR). In aortic rings of
C57Bl/6J and
eNOS+/- mice, a
competitive RT-PCR specific for the eNOS gene was performed. Total RNA
from mouse aortas was
isolated.23 A specific cDNA
fragment of 468 bp (position 3010 to
3477)24 was amplified by use
of the following primers: eNOS sense primer: 5'-GGCTCCCTCCTTCCGGCTG-3',
and eNOS antisense primer: 5'-TCCCGCAGCACGCCGAT-3'. The eNOS-specific
cDNA fragment was subsequently cloned into the pCR-Script Amp SK(+)
Cloning Vector (Stratagene), and its identity was confirmed by DNA
sequencing (ABI PRISM Dye Terminator Cycle
Sequencing Ready Reaction Kit with AmpliTaq DNA Polymerase, FS,
Perkin-Elmer Co; ABI 373 DNA Sequencer). The DNA sequence was
analyzed with Gene Runner software (Hastings Software, Inc).
Database searches of GenBank were performed with BLASTN. An internal
deleted cRNA standard of 331 bp was constructed by linker primer PCR
and identified by DNA sequencing. The internal deleted eNOS cDNA
standard was transcribed in vitro into cRNA (RNA Transcription Kit,
Stratagene). The cRNA was quantified spectrophotometrically. In
competitive RT-PCR experiments, equal amounts of total RNA (50 ng) were
incubated in separate reactions with defined amounts of eNOS standard
cRNA, reverse transcribed into cDNA (random hexamer primers), and
amplified by PCR. Reaction products were separated by agarose gel
electrophoresis. The optical density of each PCR fragment was estimated
(Biorad GelDoc 1000, Biorad), and the logarithm of the quotient of
normalized standard and sample-specific PCR fragment density was used
to calculate the equivalence point. A standard calibration curve is
given in
Figure 1
.
|
Training Protocol
Exercise was performed on a treadmill specially
designed for mice. Six animals were studied simultaneously.
Mice were initially trained 3 times for 10 minutes every other day. The
velocity of the treadmill was 15 m/min. After this training, mice were
exercised for 3 weeks 5 times a week for 30 minutes at 15 m/min. The
training was executed after 7
PM to ensure that the
exercise took place in their daily active cycle. Nonexercised controls
were exposed to the same noise and the vibration of the environment.
All mice completed the exercise protocol without signs of exhaustion.
There was no obvious difference in exercise performance between
the different genotypes. Within 16 to 20 hours after
termination of the last training, mice were euthanized by inhalation of
carbon dioxide, and their aortas and hearts were immediately frozen in
liquid nitrogen. These tissues were taken to prepare either total
protein for Western blotting or total RNA for
RT-PCR.
Statistical Analysis
Data are presented as mean±SEM. Data were
compared between groups of animals by ANOVA (Graph Pad Prism, 3.0). A
value of P<0.05 was considered
significant.
| Results |
|---|
|
|
|---|
|
|
In striking contrast, the same exercise protocol had no
effect on aortic eNOS protein expression in
eNOS+/- mice.
As shown in
Figure 4
, expression of eNOS in aortic segments of
eNOS+/- mice
was unaffected by the exercise protocol. Similarly, there was no
exercise-induced change in eNOS protein expression in the left
ventricles of these mice
(Figure 5
). These results indicate that exercise training
does not increase eNOS expression in
eNOS+/- mice
and suggest that both alleles of the eNOS gene are required for
this physiological
adaptation.
|
|
Effect of Exercise on Expression of eNOS
mRNA
To further investigate exercise-induced changes of the
eNOS gene expression, we quantified eNOS mRNA in the left cardiac
ventricle. As shown in
Figure 6A
, exercise induced a significant
1.75±0.24-fold increase in mRNA content in the heart of normal
C57BL/6J mice (P<0.05). There
was no significant difference between this effect and the increase in
eNOS protein expression as measured in separate sections of the same
cardiac tissue (1.76±0.18-fold,
Figure 4
, P=0.9732).
In accordance with the Western blot results obtained from
eNOS+/- mice,
we found no effect of exercise on eNOS mRNA expression
(Figure 6B
). This further supports the conclusion that
disruption of 1 eNOS gene results in impaired regulation of eNOS
expression in response to exercise training.
|
Effect of Exercise on the Activity of Aortic
eNOS
The effect of exercise on eNOS activity was evaluated
by determination of cGMP content in isolated mouse aortic segments
after stimulation with 1 µmol/L acetylcholine. As shown in
Figure 7
, cGMP content after stimulation with acetylcholine
was significantly increased by exercise in aortic segments of normal
C57BL/6J mice but not in aortic segments from
eNOS+/- mice.
These results indicate that the effect of exercise on eNOS expression
results in an enhanced production of a functionally active eNOS
protein and that this is absent in
eNOS+/-
mice.
|
| Discussion |
|---|
|
|
|---|
The mechanisms whereby exercise training increases eNOS expression have not been fully defined. The high cardiac output that occurs during exercise may expose the endothelium to increased levels of shear.25 In cultured endothelial cells, shear stress potently increases eNOS mRNA and protein expression.26 Exercise is also associated with an increase in oxidative stress.27 Recently, we found that even brief exposure of endothelial cells to H2O2 increases eNOS mRNA, protein, and function for up to 72 hours via both transcriptional and posttranscriptional mechanisms.28 Other humoral factors released during exercise may also contribute. It is conceivable that the effect of exercise depends on a combination of several factors.
It is interesting to consider how the absence of 1 eNOS gene may affect eNOS gene expression during exercise training. One interpretation of our results is that when 2 alleles are present, under basal conditions both are being transcribed at a submaximal rate. Exercise training may thus increase transcriptional activity of both genes. In this scenario, one might speculate that in eNOS+/- mice, the absence of 1 allele results in the opposite allele functioning at near peak transcription rate, such that it cannot be further activated by exercise training.
Another possibility is that in normal mice, 1 gene is silenced and becomes activated during exercise training. Such a phenomenon would involve methylation of 1 eNOS gene, and demethylation during exercise training. It has been shown that DNA methylation patterns are important for regulating gene expression during development and tumorigenesis.29 30 This process involves methylation of cytosines in 5'-CpG islands near the promoter of certain genes, changing interactions with repressive chromatin structures. Recently, it has become evident that the expression of certain genes is regulated by methylation and demethylation in physiological and pathophysiological states.29 31 If 1 eNOS allele were suppressed by methylation and desuppressed during exercise training, it would follow that this could not occur in mice with only 1 functional eNOS gene. Studies of the methylation status of the eNOS gene may be useful in understanding this process.
It has recently become apparent that mRNA stability plays an important role in regulation of eNOS gene expression. For example, H2O2 stimulates eNOS expression in part via mRNA stabilization, as does shear stress.21 28 How this might relate to altered expression of eNOS in eNOS+/- mice remains unclear.
Altered mRNA and protein expression of eNOS induced by exercise was associated with altered function as assessed by accumulation of aortic cGMP in response to acetylcholine. The exercise protocol we used did not lead to exhaustion of the mice, and there was no obvious difference between the exercise capacities of the different genotypes. It is quite possible, however, that mice lacking 1 eNOS gene cannot exercise as much as normal animals. Further investigations are needed to clarify this question.
Several polymorphisms of the eNOS gene have been
reported, including intron and coding sequence polymorphisms such
as the 894G
T polymorphism resulting in an exchange of
amino acid 298 from glutamate to
aspartate.17 32 33
In some cases, these have been linked to hypertension and
coronary spasm, whereas in others, they are not associated with
any obvious phenotype or disease
process.17 34 35
To date, it is not clear whether these polymorphisms alter eNOS
expression or protein function. The 894G
T polymorphism, however,
has recently been associated with decreased eNOS protein
stability.36 Our present
results, taken with our prior report, suggest that a polymorphism
of 1 gene may not affect eNOS expression or function under basal
nonstressed conditions but may alter gene expression during
physiological stresses such as exercise training.
It therefore may be useful to examine the effect of various eNOS
polymorphisms on the ability to adapt to exercise. Finally, a loss
or polymorphism of 1 eNOS gene may abrogate the beneficial effects
of exercise training in humans in terms of enhanced expression of
NOS.
| Acknowledgments |
|---|
Received August 2, 2000; revision received February 6, 2001; accepted February 15, 2001.
| References |
|---|
|
|
|---|
Asp) is a major risk factor for
coronary artery disease in the UK.
Circulation. 1999;100:15151520.
C
mutation in the 5'-flanking region of the endothelial
nitric oxide synthase gene and coronary arterial
vasomotility. Am J
Cardiol. 2000;85:710714.[Medline]
[Order article via Infotrieve]This article has been cited by other articles:
![]() |
G. M. Petzinger, J. P. Walsh, G. Akopian, E. Hogg, A. Abernathy, P. Arevalo, P. Turnquist, M. Vuckovic, B. E. Fisher, D. M. Togasaki, et al. Effects of Treadmill Exercise on Dopaminergic Transmission in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Lesioned Mouse Model of Basal Ganglia Injury J. Neurosci., May 16, 2007; 27(20): 5291 - 5300. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Adlam, J. K. Bendall, J. P. De Bono, N. J. Alp, J. Khoo, T. Nicoli, M. Yokoyama, S. Kawashima, and K. M. Channon Cardiovascular Control: Relationships between nitric oxide-mediated endothelial function, eNOS coupling and blood pressure revealed by eNOS-GTP cyclohydrolase 1 double transgenic mice Exp Physiol, January 1, 2007; 92(1): 119 - 126. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Gertz, J. Priller, G. Kronenberg, K. B. Fink, B. Winter, H. Schrock, S. Ji, M. Milosevic, C. Harms, M. Bohm, et al. Physical Activity Improves Long-Term Stroke Outcome via Endothelial Nitric Oxide Synthase-Dependent Augmentation of Neovascularization and Cerebral Blood Flow Circ. Res., November 10, 2006; 99(10): 1132 - 1140. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Searles Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression Am J Physiol Cell Physiol, November 1, 2006; 291(5): C803 - C816. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Mereles, N. Ehlken, S. Kreuscher, S. Ghofrani, M. M. Hoeper, M. Halank, F. J. Meyer, G. Karger, J. Buss, J. Juenger, et al. Exercise and Respiratory Training Improve Exercise Capacity and Quality of Life in Patients With Severe Chronic Pulmonary Hypertension Circulation, October 3, 2006; 114(14): 1482 - 1489. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. De Bono, D. Adlam, D. J. Paterson, and K. M. Channon Novel quantitative phenotypes of exercise training in mouse models Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2006; 290(4): R926 - R934. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Suvorava, N. Lauer, S. Kumpf, R. Jacob, W. Meyer, and G. Kojda Endogenous Vascular Hydrogen Peroxide Regulates Arteriolar Tension In Vivo Circulation, October 18, 2005; 112(16): 2487 - 2495. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. S. Cunha, M. Jose, C. S. Moura, C. F. Bernardes, A. P. Tanno, and F. K. Marcondes Vascular Sensitivity to Phenylephrine in Rats Submitted to Anaerobic Training and Nandrolone Treatment Hypertension, October 1, 2005; 46(4): 1010 - 1015. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. W. Franks, J. Luan, I. Barroso, S. Brage, J. L. G. Sanchez, U. Ekelund, M. S. Rios, A. J. Schafer, S. O'Rahilly, and N. J. Wareham Variation in the eNOS Gene Modifies the Association Between Total Energy Expenditure and Glucose Intolerance Diabetes, September 1, 2005; 54(9): 2795 - 2801. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Kojda and R. Hambrecht Molecular mechanisms of vascular adaptations to exercise. Physical activity as an effective antioxidant therapy? Cardiovasc Res, August 1, 2005; 67(2): 187 - 197. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Laufs, S. Wassmann, T. Czech, T. Munzel, M. Eisenhauer, M. Bohm, and G. Nickenig Physical Inactivity Increases Oxidative Stress, Endothelial Dysfunction, and Atherosclerosis Arterioscler. Thromb. Vasc. Biol., April 1, 2005; 25(4): 809 - 814. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. McAllister, J. L. Jasperse, and M. H. Laughlin Nonuniform effects of endurance exercise training on vasodilation in rat skeletal muscle J Appl Physiol, February 1, 2005; 98(2): 753 - 761. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Lauer, T. Suvorava, U. Ruther, R. Jacob, W. Meyer, D. G. Harrison, and G. Kojda Critical involvement of hydrogen peroxide in exercise-induced up-regulation of endothelial NO synthase Cardiovasc Res, January 1, 2005; 65(1): 254 - 262. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J Green, A. Maiorana, G. O'Driscoll, and R. Taylor Effect of exercise training on endothelium-derived nitric oxide function in humans J. Physiol., November 15, 2004; 561(1): 1 - 25. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Suvorava, N. Lauer, and G. Kojda Physical inactivity causes endothelial dysfunction in healthy young mice J. Am. Coll. Cardiol., September 15, 2004; 44(6): 1320 - 1327. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Momken, P. Lechene, R. Ventura-Clapier, and V. Veksler Voluntary physical activity alterations in endothelial nitric oxide synthase knockout mice Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H914 - H920. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. F. Danson, K. S. Mankia, S. Golding, T. Dawson, L. Everatt, S. Cai, K. M. Channon, and D. J. Paterson Impaired regulation of neuronal nitric oxide synthase and heart rate during exercise in mice lacking one nNOS allele J. Physiol., August 1, 2004; 558(3): 963 - 974. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Spier, M. D. Delp, C. J. Meininger, A. J. Donato, M. W. Ramsey, and J. M. Muller-Delp Effects of ageing and exercise training on endothelium-dependent vasodilatation and structure of rat skeletal muscle arterioles J. Physiol., May 1, 2004; 556(3): 947 - 958. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Laufs, N. Werner, A. Link, M. Endres, S. Wassmann, K. Jurgens, E. Miche, M. Bohm, and G. Nickenig Physical Training Increases Endothelial Progenitor Cells, Inhibits Neointima Formation, and Enhances Angiogenesis Circulation, January 20, 2004; 109(2): 220 - 226. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. K. Baskurt, O. Yalcin, S. Ozdem, J. K. Armstrong, and H. J. Meiselman Modulation of endothelial nitric oxide synthase expression by red blood cell aggregation Am J Physiol Heart Circ Physiol, January 1, 2004; 286(1): H222 - H229. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Davis, H. Cai, L. McCann, T. Fukai, and D. G. Harrison Role of c-Src in regulation of endothelial nitric oxide synthase expression during exercise training Am J Physiol Heart Circ Physiol, April 1, 2003; 284(4): H1449 - H1453. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. McNamara, R. Holubkov, L. Postava, R. Ramani, K. Janosko, M. Mathier, G. A. MacGowan, S. Murali, A. M. Feldman, and B. London Effect of the Asp298 Variant of Endothelial Nitric Oxide Synthase on Survival for Patients With Congestive Heart Failure Circulation, April 1, 2003; 107(12): 1598 - 1602. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T Gewaltig and G. Kojda Vasoprotection by nitric oxide: mechanisms and therapeutic potential Cardiovasc Res, August 1, 2002; 55(2): 250 - 260. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Schmidt, P. Andrew, A. Schrammel, K. Groschner, V. Schmitz, G. Kojda, and B. Mayer Comparison of neuronal and endothelial isoforms of nitric oxide synthase in stably transfected HEK 293 cells Am J Physiol Heart Circ Physiol, November 1, 2001; 281(5): H2053 - H2061. [Abstract] [Full Text] [PDF] |
||||
![]() |
|